Table 4.
Summary of clinical evidence of antibody therapy in ALL and selected ongoing/pending clinical trials
Adapted with permission from Ai and Advani.44 CMR indicates complete modular remission; RFS, relapse-free survival; hyper-CVAD, hyperfractionated cyclophosphamide, vincristine, doxorubicin, dexamethasone.
